
Nortriptyline
Nortriptyline is an older antidepressant with a long track record. In a 3-year trial in adults over 59 with recurrent depression who had first recovered on nortriptyline plus psychotherapy, maintenance nortriptyline cut recurrence to 43% versus 90% on placebo, and 20% when combined with psychotherapy. In a large comparison it improved depression about as much as escitalopram overall. St. John's wort and tryptophan are the high-severity supplement interactions, and alcohol is high too; CYP2D6-blocking medicines, MAO inhibitors and heart rhythm problems are the main label cautions.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with depression whose prescriber recommends a tricyclic antidepressant, including older adults whose prescriber can monitor blood levels and heart rhythm
Common dosing range
Set by your prescriber. The Pamelor label gives 25 mg three or four times daily for adults (or the total once daily), starting low and increasing as needed; above 100 mg a day, blood levels should be kept at 50 to 150 ng/mL, and doses above 150 mg a day are not recommended. Older adults and adolescents: 30 to 50 mg a day
When to expect effects
Acute comparison trial ran 12 weeks; the maintenance trial followed people for 3 years
Watch out for
Boxed warning for suicidal thoughts and behaviors in children, teens and young adults. Not for use in the acute recovery period after a heart attack. Never combine with MAO inhibitors. Dangerous in overdose. Many medicines that block CYP2D6 raise its levels
What is it
Nortriptyline is a prescription tricyclic antidepressant, sold as generic capsules and oral solution and as Pamelor capsules (10, 25, 50 and 75 mg). The Pamelor label approves it for the relief of symptoms of depression and says endogenous depressions are more likely to improve than other types. It is not recommended for children. Doctors sometimes measure its blood level to guide the dose. Its boxed warning covers suicidal thoughts and behaviors in children, teens and young adults. For supplements, St. John's wort is the high-severity interaction on this page and saffron a low-severity one.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
preventing recurrence of depression in older adults Good Evidence | Large; recurrence 43% on nortriptyline versus 90% on placebo over 3 years | Adults over 59 with recurrent, nonpsychotic major depression who responded to nortriptyline | Followed for 3 years |
moderate to severe depression compared with escitalopram Limited Evidence | No overall difference from escitalopram; differences by symptom group | Adults with moderate to severe unipolar depression | Measured over 12 weeks |
depression in primary care (tricyclic antidepressants as a class) Limited Evidence | Moderate; number needed to treat about 4 | Adults with depression treated in primary care | Typically 6 to 8 weeks |
preventing recurrence of depression in older adults
- Effect
- Large; recurrence 43% on nortriptyline versus 90% on placebo over 3 years
- Best fit
- Adults over 59 with recurrent, nonpsychotic major depression who responded to nortriptyline
- Time
- Followed for 3 years
moderate to severe depression compared with escitalopram
- Effect
- No overall difference from escitalopram; differences by symptom group
- Best fit
- Adults with moderate to severe unipolar depression
- Time
- Measured over 12 weeks
depression in primary care (tricyclic antidepressants as a class)
- Effect
- Moderate; number needed to treat about 4
- Best fit
- Adults with depression treated in primary care
- Time
- Typically 6 to 8 weeks
Evidence for 3 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
preventing recurrence of depression in older adults
Disease adjunctIn a 3-year, double-blind, placebo-controlled trial, 107 adults over 59 (average age 67) who had recovered from recurrent major depression on nortriptyline plus interpersonal psychotherapy were randomized to four maintenance options. Recurrence rates were 20% with nortriptyline plus psychotherapy, 43% with nortriptyline alone, 64% with psychotherapy plus placebo, and 90% with placebo alone. Nortriptyline was dosed to blood levels of 80 to 120 ng/mL. People aged 70 and older relapsed more often and sooner.
Bottom line: In older adults who recovered on nortriptyline, staying on it greatly reduced depression coming back, especially with psychotherapy.
moderate to severe depression compared with escitalopram
Disease adjunctThe GENDEP study allocated 811 adults with moderate to severe unipolar depression to flexible-dose escitalopram or nortriptyline for 12 weeks, in a part-randomized, open-label design. On the three standard depression scales there was no difference between the two drugs. Looking at symptom groups, mood and thinking symptoms improved more with escitalopram, while sleep, appetite and energy symptoms improved more with nortriptyline. There was no placebo group.
Bottom line: Nortriptyline improved depression about as much as escitalopram overall, with different symptom strengths.
depression in primary care (tricyclic antidepressants as a class)
Disease adjunctA 2005 meta-analysis of placebo-controlled trials in primary care included 10 studies comparing tricyclic antidepressants with placebo (and 2 more that tested both a tricyclic and an SSRI) and found more improvement than with placebo (relative risk 1.26, 95% CI 1.12 to 1.42), with about 4 people treated for one extra to improve. Half of the studies were of low quality, nearly all lasted only 6 to 8 weeks, and the number needed to harm (one extra person stopping because of side effects) was 5 to 11 for tricyclics. The abstract reports tricyclics as a group, not nortriptyline alone.
Bottom line: Tricyclic antidepressants, the class nortriptyline belongs to, worked better than placebo in primary care but caused more side-effect dropouts.
How it works
How to take it
What to track
Bottom line: Your prescriber sets the dose and may check blood levels; keep St. John's wort and new medicines out unless your prescriber agrees, and do not stop suddenly on your own.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Suicidal thoughts and behaviors (boxed warning). In pooled trials, antidepressants increased these in people under 25 (14 extra cases per 1,000 under 18 and 5 per 1,000 aged 18 to 24); everyone starting nortriptyline should be watched closely for worsening.
Heart effects: fast heart rate and slowed conduction; heart attack, arrhythmia and stroke have occurred. The label says people with heart disease should take it only under close supervision, and it can unmask Brugada syndrome.
Serotonin syndrome, a potentially life-threatening reaction, especially with other serotonergic products (triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John's wort) or MAO inhibitors.
Overdose can be fatal, with heart rhythm problems, severe low blood pressure, seizures and coma. The label says the smallest practical quantity should be dispensed because of suicide risk in depression.
Other label warnings: lower seizure threshold, worsening psychosis or switch to mania, angle-closure glaucoma, urinary retention, rises or falls in blood sugar, bone marrow suppression including agranulocytosis, confusion in older adults, and arrhythmias with thyroid medicine or an overactive thyroid.
Who should avoid it
- People taking an MAO inhibitor for a psychiatric condition or within 14 days of stopping one, and people being treated with linezolid or intravenous methylene blue (contraindicated)
- People in the acute recovery period after a heart attack (contraindicated), and people with possible cross-sensitivity to related tricyclic drugs
- Children: the label says Pamelor is not recommended for children and nortriptyline is not approved for pediatric patients
- People with Brugada syndrome or suspected Brugada syndrome: the label says nortriptyline should generally be avoided
Pregnancy & breastfeeding
The Pamelor label covers pregnancy and breastfeeding in one statement: safe use during pregnancy and lactation has not been established, so when the drug is given to pregnant women, nursing mothers or women who could become pregnant, the possible benefits must be weighed against the possible hazards. It adds that animal reproduction studies gave inconclusive results. Pregnancy: the label gives no further pregnancy data. Breastfeeding: the label gives no further data on breast milk or breastfed infants. Discuss both with your prescriber.
Interactions
Contraindicated because of an increased risk of serotonin syndrome. The label requires at least 14 days between stopping an MAOI and starting nortriptyline, and at least 14 days after stopping nortriptyline before starting an MAOI.
In 12 patients taking amitriptyline, which the body converts to nortriptyline, adding St. John's wort extract (900 mg a day) for about 2 weeks lowered nortriptyline exposure by 41%, with levels already clearly lower after 3 days; this could weaken the antidepressant effect. The Pamelor label also lists St. John's wort among serotonergic products that raise the risk of serotonin syndrome. Avoid combining them unless your prescriber advises it, and do not stop the herb on your own if you already take both, since nortriptyline levels can change again.
The label says these can make a person who is stable on nortriptyline abruptly toxic, because they slow its clearance; plasma levels of a tricyclic can rise up to 8-fold in CYP2D6 poor metabolizers. Lower nortriptyline doses and blood level checks may be needed when one is started, and higher doses when one is stopped. After stopping fluoxetine, the label says at least 5 weeks may be needed before starting a tricyclic.
The label says combining these with nortriptyline raises the risk of serotonin syndrome, particularly when starting or increasing a dose, and that patients should be told of the risk when such a combination is used. Seek urgent care for agitation, tremor, fever, fast heartbeat, heavy sweating or muscle stiffness.
The Pamelor label lists tryptophan among serotonergic products that raise the risk of serotonin syndrome, and says that if such a combination is clinically warranted, patients should be told of the risk, particularly when treatment starts or the dose goes up. No published case with this exact pair was found. Do not add a tryptophan supplement unless your prescriber advises it.
The Pamelor label says the response to alcohol may be exaggerated and that nortriptyline can impair driving skills on its own. It also warns that excessive drinking with nortriptyline may have a potentiating effect that can lead to the danger of increased suicide attempts or overdose, especially in people with a history of emotional disturbances or suicidal thoughts. Avoid alcohol or keep it to a minimum, and discuss your drinking with your prescriber or pharmacist.
Saffron may act partly through serotonin, which raises a theoretical concern about added serotonin effects. No trial has tested saffron with nortriptyline. In a placebo-controlled trial in 160 adults already taking an antidepressant, a standardized saffron extract (14 mg twice daily) for 8 weeks improved clinician-rated depression scores, but not self-rated scores, without increasing antidepressant side effects; its abstract does not name the antidepressants taken. The only trial that names them, a 4-week pilot in 40 adults, added crocin, a saffron compound, to the SSRIs fluoxetine, sertraline or citalopram. Discuss it with your prescriber before adding saffron.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (3)
+ alcohol
highNortriptyline is a tricyclic antidepressant that can impair the mental and physical skills needed for driving, and its label says the response to alcohol may be exaggerated. The Pamelor label also warns that excessive drinking with nortriptyline may have a potentiating effect that can lead to the danger of increased suicide attempts or overdose, especially in people with a history of emotional disturbances or suicidal thoughts. The warnings come from the FDA label; we found no controlled study measuring how much alcohol adds to nortriptyline's effects.
+ st. john's wort
highIn 12 patients taking amitriptyline, which the body converts to nortriptyline, adding St. John's wort extract lowered nortriptyline exposure by 41%, with levels already clearly lower after 3 days; this can weaken the antidepressant effect. The study authors suggested induction of liver enzymes or of the P-glycoprotein transporter as the cause. The Pamelor label also lists St. John's wort among serotonergic products that raise the risk of serotonin syndrome.
+ tryptophan
highNortriptyline is a tricyclic antidepressant that its label treats as serotonergic, and L-tryptophan is the amino acid the body turns into serotonin. The Pamelor label lists tryptophan among the serotonergic products that raise the risk of serotonin syndrome, a potentially life-threatening reaction, and says patients should be told of that risk if the combination is clinically warranted, particularly when treatment starts or the dose goes up. The warning rests on the label and the shared mechanism: no published case of serotonin syndrome from this exact pair was found.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take St. John's wort with nortriptyline?⌄
This page rates it a high-severity interaction. In a study of 12 patients taking amitriptyline, which the body turns into nortriptyline, St. John's wort lowered nortriptyline levels by 41%; that study did not include people prescribed nortriptyline itself. Lower levels could weaken it, and the Pamelor label lists the herb among products that raise the risk of serotonin syndrome. Talk to your prescriber before using it, and if you already take both, contact your prescriber rather than stopping anything on your own.
Can I take saffron supplements with nortriptyline?⌄
The concern is theoretical. Saffron may act partly on serotonin, but no trial has tested it with nortriptyline. The studies that exist added saffron to unnamed antidepressants, or a saffron compound to the SSRIs fluoxetine, sertraline or citalopram, without more side effects. This page rates the pair low severity. Ask your prescriber before starting it.
Can I drink alcohol while taking nortriptyline?⌄
Ask your prescriber. The Pamelor label says the response to alcohol may be exaggerated, and that heavy drinking with nortriptyline may increase the danger of overdose or suicide attempts in people with emotional difficulties or suicidal thoughts.
Why does my doctor check my nortriptyline blood level?⌄
Levels vary a lot between people, partly because of the CYP2D6 enzyme and other medicines that block it. The label says that above 100 mg a day, blood levels should be monitored and kept at 50 to 150 ng/mL, and that checking levels is useful when a CYP2D6-blocking drug is added.
What happens if I stop nortriptyline suddenly?⌄
The label says stopping abruptly after long use may cause nausea, headache and malaise. Talk to your prescriber before making any change, so a plan can be made.
References by claim
preventing recurrence of depression in older adults
Reynolds CF 3rd et al., 1999 · PubMed (1999) link
moderate to severe depression compared with escitalopram
Uher et al., 2009 · PubMed (2009) link
depression in primary care (tricyclic antidepressants as a class)
Arroll et al., 2005 · PMC (2005) link
Safety
Pamelor (nortriptyline HCl) capsules prescribing information · DailyMed (FDA label) link
Interaction: St. John's wort (Hypericum perforatum)
Johne et al., 2002 · PubMed (2002) link
Track Nortriptyline with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
